Abbonarsi

Associations of N-terminal pro-B-type natriuretic peptide, estimated glomerular filtration rate, and mortality in US adults - 13/09/23

Doi : 10.1016/j.ahj.2023.05.014 
Bige Ozkan, MD, ScM a, b, Morgan E. Grams, MD, PhD c, Josef Coresh, MD, PhD a, John W. McEvoy, MB, BCh, BAO, MHS, PhD d, Justin B. Echouffo-Tcheugui, MD, PhD e, Scott Z. Mu, MD, MHS a, Olive Tang, MD, PhD f, Natalie R. Daya, MPH a, Hyunju Kim, PhD, MPH a, Robert H. Christenson, PhD g, Chiadi E. Ndumele, MD, PhD b, Elizabeth Selvin, PhD, MPH a,
a Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 
b Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD 
c Division of Precision Medicine Research, New York University Grossman School of Medicine, New York, NY 
d Division of Cardiology and National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland 
e Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD 
f Johns Hopkins University School of Medicine, Baltimore, MD 
g Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 

Reprint requests: Elizabeth Selvin, PhD, MPH, Epidemiology, and Clinical Research and the Johns Hopkins Bloomberg School of Public Health, 2024 E Monument Street, Suite 2-639, Baltimore, MD 21287.Epidemiology, and Clinical Research and the Johns Hopkins Bloomberg School of Public Health2024 E Monument Street, Suite 2-639BaltimoreMD21287

Riassunto

Background

NT-proBNP is an important predictor of mortality but is inversely related to estimated glomerular filtration rate (eGFR). Whether the prognostic value of NT-proBNP is similar at different levels of kidney function is unknown.

Aims

We evaluated the association of NT-proBNP with eGFR and its implications for all-cause and cardiovascular mortality risk in the general population.

Methods

We included adults without prior cardiovascular disease from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. We used linear regression to characterize the cross-sectional associations of NT-proBNP with eGFR. We used Cox regression to assess the prospective associations of NT-proBNP with mortality across categories of eGFR.

Results

Among 11,456 participants (mean age 43 years, 48% female, 71% White, 11% Black), there was an inverse association between NT-proBNP and eGFR, which was stronger in those with more impaired kidney function. Per 15-unit decrease in eGFR, NT-proBNP was 4.3-fold higher for eGFR<30; 1.7-fold higher for eGFR 30 to 60, 1.4-fold higher for eGFR 61 to 90, 1.1-fold higher for eGFR 91 to 120 mL/min/1.73 m2. Over a median 17.6 years of follow-up, 2,275 deaths (622 cardiovascular) occurred. Higher NT-proBNP was associated with higher all-cause (HR per doubling of NT-proBNP: 1.20, 95% CI: 1.16-1.25) and cardiovascular mortality (HR: 1.34, 95% CI 1.25-1.44). Associations were similar across eGFR categories (P-interaction >.10). Adults with NT-proBNP≥450 pg/mL and eGFR<60 mL/min/1.73m2 had 3.4-fold higher all-cause mortality and 5.5-fold higher cardiovascular mortality risk, compared to those with NT-proBNP<125 pg/mL and eGFR>90 mL/min/1.73m2.

Conclusion

Despite its strong inverse association with eGFR, NT-proBNP has robust associations with mortality across the full range of kidney function in the general US adult population.

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract




 : 

In this analysis of US adults, individuals with more impaired kidney function had significantly higher NT-proBNP levels, but NT-proBNP had similar mortality associations at all levels of kidney function. Individuals with the combination of impaired kidney function and elevated NT-proBNP levels had the highest all-cause and cardiovascular mortality risk.


In this analysis of US adults, individuals with more impaired kidney function had significantly higher NT-proBNP levels, but NT-proBNP had similar mortality associations at all levels of kidney function. Individuals with the combination of impaired kidney function and elevated NT-proBNP levels had the highest all-cause and cardiovascular mortality risk.Image, graphical abstract

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ACR, CKD, CVD, eGFR, NHANES, NT-proBNP


Mappa


© 2023  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 264

P. 49-58 - ottobre 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE
  • Kamal Gupta, Harsh Mehta, Hwasoon Kim, Amanda Stebbins, Lisa M. Wruck, Daniel Muñoz, Mark B. Effron, R. David Anderson, Carl J. Pepine, Sandeep K. Jain, Saket Girotra, Darren A. DeWalt, Jeff Whittle, Catherine P. Benziger, Peter Farrehi, Li Zhou, Kirk U. Knowlton, Tamar S. Polonsky, Steven M. Bradley, Robert A. Harrington, Russell L. Rothman, W. Schuyler Jones, Adrian F. Hernandez
| Articolo seguente Articolo seguente
  • Transcatheter edge-to-edge repair for chronic functional mitral regurgitation in patients with very severe left ventricular dysfunction
  • Alon Shechter, Ofir Koren, Sabah Skaf, Moody Makar, Tarun Chakravarty, Keita Koseki, Danon Kaewkes, Aum Solanki, Vivek Patel, Raj R. Makkar, Robert J. Siegel

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.